LIDODERM Drug Patent Profile
✉ Email this page to a colleague
When do Lidoderm patents expire, and when can generic versions of Lidoderm launch?
Lidoderm is a drug marketed by Teikoku Pharma Usa and is included in one NDA.
The generic ingredient in LIDODERM is lidocaine. There are twenty-nine drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the lidocaine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lidoderm
A generic version of LIDODERM was approved as lidocaine by ACTAVIS LABS UT INC on August 23rd, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIDODERM?
- What are the global sales for LIDODERM?
- What is Average Wholesale Price for LIDODERM?
Summary for LIDODERM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 131 |
| Clinical Trials: | 22 |
| Patent Applications: | 6,002 |
| Drug Prices: | Drug price information for LIDODERM |
| What excipients (inactive ingredients) are in LIDODERM? | LIDODERM excipients list |
| DailyMed Link: | LIDODERM at DailyMed |
Recent Clinical Trials for LIDODERM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nicole K Brogden | Phase 4 |
| Long Island University | Phase 4 |
| University of Iowa | Phase 4 |
Pharmacology for LIDODERM
| Drug Class | Amide Local Anesthetic Antiarrhythmic |
| Physiological Effect | Local Anesthesia |
US Patents and Regulatory Information for LIDODERM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for LIDODERM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| Teikoku Pharma Usa | LIDODERM | lidocaine | PATCH;TOPICAL | 020612-001 | Mar 19, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LIDODERM
See the table below for patents covering LIDODERM around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Singapore | 50517 | External preparation for aplication to the skin containg lidocine | ⤷ Sign Up |
| Germany | 69217685 | ⤷ Sign Up | |
| Japan | 2515902 | ⤷ Sign Up | |
| Germany | 69433859 | ⤷ Sign Up | |
| France | 2683225 | PROCEDE POUR AMELIORER UNE HUILE GLYCEROLYSEE. | ⤷ Sign Up |
| Norway | 951217 | ⤷ Sign Up | |
| European Patent Office | 0674913 | Corps adhésif non-occlusif pour l'administration d'un médicament à la peau (Non-occulusive adhesive patch for applying medication to the skin) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
